6533b82bfe1ef96bd128cd4a
RESEARCH PRODUCT
Lycopene and Vascular Health
Ioana MozosIoana MozosDana StoianAlexandru CarabaClemens MalainerJarosław O. HorbańczukAtanas G. AtanasovAtanas G. Atanasovsubject
0301 basic medicinecardiovascular riskAntioxidantmedicine.medical_treatmentContext (language use)Review030204 cardiovascular system & hematologyPharmacology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineendothelial functionmedicinePharmacology (medical)intima-media thicknessCarotenoidPharmacologychemistry.chemical_classificationVascular diseasebusiness.industrylcsh:RM1-950medicine.diseaselycopeneLycopene030104 developmental biologyarterial stiffnesslcsh:Therapeutics. PharmacologychemistryIntima-media thicknessArterial stiffnessMetabolic syndromebusinessdescription
Lycopene is a lipophilic, unsaturated carotenoid, found in red-colored fruits and vegetables, including tomatoes, watermelon, papaya, red grapefruits, and guava. The present work provides an up to date overview of mechanisms linking lycopene in the human diet and vascular changes, considering epidemiological data, clinical studies, and experimental data. Lycopene may improve vascular function and contributes to the primary and secondary prevention of cardiovascular disorders. The main activity profile of lycopene includes antiatherosclerotic, antioxidant, anti-inflammatory, antihypertensive, antiplatelet, anti-apoptotic, and protective endothelial effects, the ability to improve the metabolic profile, and reduce arterial stiffness. In this context, lycopene has been shown in numerous studies to exert a favorable effect in patients with subclinical atherosclerosis, metabolic syndrome, hypertension, peripheral vascular disease, stroke and several other cardiovascular disorders, although the obtained results are sometimes inconsistent, which warrants further studies focusing on its bioactivity.
year | journal | country | edition | language |
---|---|---|---|---|
2018-05-23 | Frontiers in Pharmacology |